United Therapeutics Corporation (UTHR) has a market capitalization of $25.36B and trades at $578.54. The 52-week range is 266.98-607.89.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 19.2, Earnings Per Share (EPS) of $30.13, annual revenue of $3.18B.
The stock has a beta of 0.75, operates in the Healthcare sector.
